Tandem Labs serves the pharmaceutical, biopharmaceutical, and biotechnical industry by combining advanced analytical instrumentation with superior technical expertise. We develop, validate, and perform mass spectrometry-based methods in support of clinical, pre-clinical, and discovery studies in a stringent GLP environment.
A summary of our services is as follows: GLP Bioanalytical Services:
* Method development * Method validation * Dose formulation analysis * Pre-clinical and clinical sample analysis * TK/PK analysis and reporting * Protein-binding studies.
GLP Immunoanalytical Services:
* Biomarker assay development, validation, and sample analysis * Ligand-binding assays * Biotherapeutic macromolecule PK * Immunogenicity assays * Cell-based assays (bioassays) * Quantitative immunoassays: EIA, CIA, FIA, IRMA, SPA * Electrochemiluminescence using MSD & BioVerisT * Multiplexed assays.
Rapid Turnaround Non-GLP Discovery Services:
* Protein-binding assays * Discovery bioanalysis (non-GLP, PK screening through candidate selection, and optimization)
Biotransformation and Pharmacodynamics (PK/PD) Services:
* DMDiscoverySM for drug metabolite profiling, identification, and quantification * MarkerScanSM for biomarker discovery and screening.
At Tandem we are dedicated to meeting the highest standards of personal service, integrity of data, and timeliness for every client.